Nearly 29,000 units of red blood cells (RBC) are needed every day in the U.S.1 Blood transfusions are a vitally important therapy but remain one of the most overused procedures.2 Blood products are often at critically low inventory levels, increasing the pressure for organizations to ensure effective patient blood management.
CHNw sought to improve the effectiveness of patient blood management to ensure that costly, limited blood products were appropriately used for patients who could benefit the most from the therapy. Still, the organization lacked data and analytics, impeding improvement efforts.
Obtaining the data required to evaluate performance and identify improvement opportunities required substantial time and were burdensome. Data were spread across multiple sources, including the EHR, blood bank, and financial department. When CHNw finally obtained data from these sources, it often experienced data-quality issues. Data from different sources sometimes conflicted and were difficult to reconcile. CHNw needed a solution that would provide timely, actionable insights that could be used to better manage limited blood supplies and improve performance.
CHNw chose to use the Health Catalyst® Data Operating System (DOS™) platform and a robust suite of analytics applications, including the Blood Utilization analytics accelerator and Healthcare.AI, to gain access to the high-value data and analytics, and actionable insights required to improve patient blood management effectiveness.
CHNw uses the Blood Utilization analytics accelerator and Healthcare.AI to see, understand, and improve patient blood management. Using the analytics accelerator, the organization can quickly and effectively visualize the:
With the new insights gained from the analytics application, the organization targeted reducing the RBC utilization rate and ensuring adherence to transfusion best practices. It developed and implemented a standard blood product order set, including a restrictive transfusion strategy by Hgb level. CHNw also provided education and support for registered nurses and providers about using the order set and education about the most recent patient blood management best practices and communicated the expectation that providers enter blood orders using computerized provider order entry.
The new insights also supported the organization’s decision for updated decision support in the EHR to ensure alerts appeared in the right workflow for the right provider. The alerts inform the ordering provider if there is no Hgb and prompt the provider to order and review the Hgb before ordering a transfusion. If the Hgb is greater than 7-8 g/dL, the alert encourages the provider to reconsider transfusion, indicating transfusion is not recommended in hemodynamically stable patients. The alert can be bypassed if an emergent/massive transfusion is required.
Healthcare.AI integration provides one-button augmented intelligence within the Blood Utilization analytics accelerator, enabling CHNw to produce higher-quality, faster insights. CHNw trusts the high-value and high-quality data in the analytics application. Data are integrated from multiple source systems, integrated, and aggregated so CHNw can immediately identify and manage variations in practice and performance trends over time. Integrated statistical process control charts support CHNw quickly drawing more accurate and consistent conclusions about performance and improvement opportunities. The organization uses its rich, high-quality data and analytics to engage providers in continually improving patient blood management effectiveness.
“The Health Catalyst Blood Utilization analytics accelerator provides us the high-quality data and analytics required to truly understand our performance and drive improvements. We successfully reduced the number of red blood cells transfused annually, saving more than $1.2M.”M. Danielle Dillon, MHL, BSN, RN, CCRN-K, Blood Management Director, Quality & Safety, Community Health Network
CHNw’s data-informed patient blood management has decreased unnecessary transfusions and improved the management of a costly, limited resource resulting in:
The analytics accelerator has also enabled CHNw to identify previously hidden improvement opportunities. For example, because of the high-quality data in the analytics accelerator, the organization was able to identify opportunities to decrease the waste of fresh frozen plasma.
CHNw is continuing to improve the effectiveness of patient blood management. The organization is implementing new processes to improve preoperative anemia management for patients undergoing elective surgery. Additionally, CHNw is standardizing a provider champion-driven approach to conducting crucial conversations with providers who do not have clinical indications in ordering blood products and escalating trends via appropriate safety event reporting mechanisms. The organization is also optimizing massive transfusion protocol use and practice in conjunction with OR, maternity, and education leaders.